Search results

Selected filters:

Valuation

Article type

Topic

Sector

Regions

1,850 results found for your search

Sort options
19 July 2019

Alphabet is trimming down its portfolio - but only after sustained growth  

The tech giant saw a steep drop in the number of US patents granted in 2018 after having spent years building its portfolio organically and through strategic acquisitions

16 July 2019

Gilead’s unique $5.1 billion licensing deal shows the range of IP monetisation options open to biotech sector

New boss explains that the Big Pharma company will seek out “diverse and creative” asset partnerships – rather than large acquisitions – to boost its pipeline

08 July 2019

Bankrupt mobile firm's patents could hit the market soon

It wouldn't be the summer’s biggest auction, but Gionee’s China-heavy smartphone patent portfolio could draw interest from Chinese operating companies and NPEs focused on the market

05 July 2019

Get ready for the first CRISPR patent pool

In an exclusive interview, MPEG LA’s Kristin Neuman says that a pool is on its way despite the UCal v Broad stand-off and talks about the future of licensing in biotech’s ‘golden age’

02 July 2019

AbbVie’s Allergan play designed to mitigate Humira patent cliff

The $63 billion purchase is designed to mitigate the effects of losing the exclusive rights to the world’s best selling drug

29 June 2019

Faraday Future’s patent portfolio may be small, but it packs a punch

The struggling electric vehicle start-up has invested significantly in building its assets, and while it trails behind competitors it has a number of holdings in valuable areas which may come in handy

28 June 2019

Politics, money could temper Chinese interest in Intel auction

A few years ago, it might have been different. But political, legal and economic uncertainty may combine to keep firms like Huawei and ZTE out of the running for Intel’s wireless IP

22 June 2019

United Technologies to become aerospace and defence behemoth with Raytheon merger

The Farmington-based company has ramped up its own patent activity, and the proposed deal will expand its technologies and R&D capabilities to compete with the likes of Boeing  

13 June 2019

How Apple uses patents to win

The iPhone giant’s portfolio is at the heart of the defence it plays when the subject of an assertion – and analysis shows that much of it has been acquired rather than grown organically

13 June 2019

Huawei’s $1 billion Verizon demand: politics or profit?

Ongoing royalty negotiations are revealed after US network operator reportedly notifies government. Why the conflict, which follows a 2016 dispute with T-Mobile, may alarm Nokia and Ericsson

12 June 2019

IAM and sister publication GDR launch major data event

The Data Business Congress will take place in San Jose, CA, next February with the focus on the capture, protection, management, exploitation and monetisation of one of the pivotal assets of the 21st century

07 June 2019

Roche trumps rivals with strongest biotech patent portfolio

Trailing behind the Swiss giant are DowDuPont and Bayer, both of which have seen a drop in the value of their holdings

04 June 2019

IP3 deals platform makes key rule change to drum up more seller interest

Patent owners will not be required to take assets off the market after making submissions; this year's programme also features new sector focus areas

03 June 2019

Deloitte makes major IP play with acquisition of top advisory

Big Four firm closes deal to acquire UK-based ClearView in a further sign that IP value creation is moving to the centre of the corporate agenda 

01 June 2019

A rotten Apple standard

In a blistering opinion piece, former Vringo chief legal officer David Cohen accuses the iPhone giant of deliberately plotting to destroy SEP licensing